Interesting that Cephalon is the partner in this deal. If you check out the annual report of Chemgenex, another Aussie biotech, you might get a clue as to who their next target is. They have deep pockets.
cephalon's next target
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1569 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 12450 | 2 |
View Market Depth
| Last trade - 09.42am 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable